The University of Cincinnati Gardner Neuroscience Institute (UCGNI) has unveiled a significant change in its leadership with the appointment of Dr. Brett Kissela as the new director. This development is more than just a change of guard; it represents a strategic pivot toward advancing neurological
In a monumental stride for pharmaceutical chemistry, researchers have developed a groundbreaking new class of ultra-stable chiral molecules that could redefine drug efficacy and safety. Chiral molecules, akin to a pair of gloves where the left and right hands are mirror images, play a pivotal role
The situation in Pinar del Río, Cuba, has become increasingly precarious as health risks surge due to a dengue outbreak affecting municipalities such as Guane, Sandino, Los Palacios, Pinar del Río, and San Luis. Current circumstances have culminated in San Luis being officially designated as an
In an era marked by rapid advancements in biotechnology, gene editing emerges as a promising frontier in the treatment of cardiovascular diseases. With the acquisition of Verve Therapeutics by Eli Lilly and Co., the pharmaceutical industry witnesses a strategic shift as major players venture deeper
The small town of Ashfield has made a significant strategic move to enhance its public health services by transferring management responsibilities to the Franklin Regional Council of Governments (FRCOG). Following the resignation of Claudia Sarti, the town’s part-time Health Agent, Ashfield’s Board
In the quest to unravel the complexities of the human brain, researchers often focus on activities associated with alert states, overlooking the intricate workings during rest. Recent groundbreaking studies are redefining this approach, revealing a treasure trove of information encoded in the
